Concepedia

Author

P. Habermehl

Johannes Gutenberg University Mainz

Also Known As

P Habermehl, P. Habermehl, Peter Habermehl

13

Publications

471

Citations

8

H-Index

20

Concepts

All Affiliations

Johannes Gutenberg University MainzChristian-Albrechts-Universität zu KielGlaxoSmithKline (United Kingdom)
PH

About

P. Habermehl is an author at Johannes Gutenberg University Mainz specializing in medicine, immunology, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

349

2

Immunology

5

5

331

3

Hepatology

1

1

18

4

Autoimmune Disease

1

1

96

5

Autoimmunity

1

1

96

P. Habermehl

×

8

Publications

459

Citations

8

H-Index

YearCitations

When Good Intentions Go Bad—False Positive Microplastic Detection Caused by Disposable Gloves

Cordula S. Witzig, Corinna Földi, Katharina Wörle,

Environmental Science & Technology

2020

99

Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine

Fred Zepp, Markus Knuf, P. Habermehl,

Infection and Immunity

1996

96

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b - PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine

Fred Zepp, H. J. Schmitt, Achim Kaufhold,

European Journal of Pediatrics

1996

92

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

Markus Knuf, Dorothee Kieninger‐Baum, P. Habermehl,

Vaccine

2009

75

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age

Giovanni Gabutti, Fred Zepp, Lode Schuerman,

Scandinavian Journal of Infectious Diseases

2004

38

Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately

Roland Saenger, Gudrun Maechler, M. Potreck,

Vaccine

2004

30

Safety and efficacy of interferon retreatment in children with chronic hepatitis B

Antje Ballauff, Thomas Schneider, Patrick Gerner,

European Journal of Pediatrics

1998

18

Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies.

Josef Weigl, H.L. Bock, Ralf Clemens,

PubMed

1997

11

Page 1